Naoki Kumashiro
11PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Apr 12, 2023
Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: A sub-analysis of the DIVERSITY-CVR study.Kota Takuma, Ayako Fuchigami, Fumika Shigiyama
|Feb 07, 2023
Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue-specific insulin sensitivity in patients with early-stage type 2 diabetes with non-alcoholic fatty liver disease: A prospective randomized study.Shigenori Hiruma, Fumika Shigiyama, Naoki Kumashiro
|Mar 02, 2021
Simplification of complex insulin regimens using canagliflozin or liraglutide in patients with well-controlled type 2 diabetes: A 24-week randomized controlled trial.Yasuyo Ando, Fumika Shigiyama, Takahisa Hirose
|Feb 03, 2021
A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.Shigenori Hiruma, Fumika Shigiyama, Shinji Hisatake
|Jan 09, 2020
Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR).Ayako Fuchigami, Fumika Shigiyama, Toru Kitazawa
|Jul 18, 2019
Whole hepatic lipid volume quantification and color mapping by multi-slice and multi-point magnetic resonance imaging.Hiroyuki Igarashi, Fumika Shigiyama, Noritaka Wakui
Pageof 2
